Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

VOLUNTARY ANNOUNCEMENT – COLLABORATION WITH ARRIVENT IN RELATION TO THE RESEARCH, DEVELOPMENT AND COMMERCIALIZATION OF ADC PRODUCTS 2024-06-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 2024-06-03
VOLUNTARY ANNOUNCEMENT – RESEARCH UPDATES ON A PHASE I/II CLINICAL STUDY OF JSKN003 FOR THE TREATMENT OF ADVANCED SOLID TUMORS FOR PRESENTATION AT 2024 ASCO ANNUAL MEETING 2024-06-03
INSIDE INFORMATION ANNOUNCEMENT – UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED PDAC 2024-05-28
Next Day Disclosure Return 2024-05-28
VOLUNTARY ANNOUNCEMENT – FIRST PATIENT DOSED IN A PHASE I CLINICAL TRIAL OF JSKN016 FOR THE TREATMENT OF ADVANCED MALIGNANT SOLID TUMORS 2024-05-21
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 12, 2024 2024-05-20
NOTICE OF ANNUAL GENERAL MEETING 2024-05-20
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES (INCLUDING RESELL OR TRANSFER TREASURY SHARES); (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; (4) PROPOSED AMENDMENTS TO THE POST-IPO SHARE OPTION SCHEME; (5) PROPOSED AMENDMENTS TO THE RESTRICTED SHARE AWARD SCHEME; (6) PROPOSED REFRESHMENT OF THE SCHEME MANDATE LIMIT; AND (7) NOTICE OF ANNUAL GENERAL MEETING 2024-05-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 2024-05-07